Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 259-134-5 | CAS number: 54381-16-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Repeated dose toxicity: dermal
Administrative data
- Endpoint:
- sub-chronic toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 1976
- Reliability:
- 3 (not reliable)
- Rationale for reliability incl. deficiencies:
- other: Does not meet important criteria of today standard methods
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 976
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Male and female New Zealand White rabbits were used in the study. 6 animals/sex were used in each group. The hair at the site of application on the back and sides of each animal was clipped short throughout the study. The thoracic-lumbar area (one on each side of the midline) was re alternated to minimize skin irritation. The application sites on three animals of each sex in each group were abraded on the first treatment day of each week.
Animals were observed for clinical signs, dermal irritation and body weight changes during the study period. Urine and blood samples were collected at 0, 3, 7, and 13 weeks of the study to determine the various parameters. Animals were sacrificed after 13 wk and examined for gross abnormalities. Tissue samples were collected to perform histology. Organ-body weight ratios were determined for liver, kidneys, adrenals, heart, thyroid, spleen, and brain. - GLP compliance:
- no
- Limit test:
- no
Test material
- Reference substance name:
- (p-ammoniophenyl)bis(2-hydroxyethyl)ammonium sulphate
- EC Number:
- 259-134-5
- EC Name:
- (p-ammoniophenyl)bis(2-hydroxyethyl)ammonium sulphate
- Cas Number:
- 54381-16-7
- Molecular formula:
- C10H16N2O2.H2O4S
- IUPAC Name:
- (p-ammoniophenyl)bis(2-hydroxyethyl)ammonium sulphate
- Reference substance name:
- N,N-Bis-(2-hydroxyethyl)-p-phenylenediamine sulfate
- IUPAC Name:
- N,N-Bis-(2-hydroxyethyl)-p-phenylenediamine sulfate
- Details on test material:
- - Name of test material: Two formulations containing 0.5% (P22) and 1% (P21) of N,N-Bis-(2-hydroxyethyl)-p-phenylenediamine sulfate
- Substance type: Other
- Physical state: Not reported
No other information on details of formulations was provided in the study report.
Constituent 1
Constituent 2
Test animals
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS: No other information on test animals was provided in the study report.
- Housing: Animals were housed in cages.
ENVIRONMENTAL CONDITIONS: No details on environmental conditions were provided in the study report.
Administration / exposure
- Type of coverage:
- open
- Vehicle:
- water
- Details on exposure:
- TEST SITE: The thoracic-lumbar area (one on each side of the midline) was alternated to minimize skin irritation.
- Area of exposure: Not reported
- % coverage: Not reported
- Type of wrap if used: Not reported
- Time intervals for shavings or clipplings: The hair at the site of application on the back and sides of each animal was clipped short throughout the study.
- The application sites on three animals of each sex in each group were abraded on the first treatment day of each week.
REMOVAL OF TEST SUBSTANCE
- Washing: Animals were shampooed, rinsed, dried, and returned to their cages.
- Time after start of exposure: 1 h
TEST MATERIAL
- Amount applied: 1 mL/Kg bw, this was the maximum dose that could be applied on the side of the rabbits without runoff.
- Concentration: Formulation 1 (P21) and 2 (P22) contained 1% and 0.5% of test substance, respectively. Formulation 1 containing test substance (1%) was mixed with an equal volume of 6% hydrogen peroxide just before use.
- Constant volume or concentration used: Yes
VEHICLE: Water
USE OF RESTRAINERS FOR PREVENTING INGESTION: Yes, the animals were restrained in holding stocks for 1 h following each application. - Analytical verification of doses or concentrations:
- no
- Duration of treatment / exposure:
- 13 weeks
- Frequency of treatment:
- Twice/week
Doses / concentrationsopen allclose all
- Remarks:
- Prior to treatment, formulation 1 was mixed with equal volume of 6% hydrogen peroxide.
- No. of animals per sex per dose:
- 6 animals/sex/group
- Control animals:
- yes, concurrent no treatment
- Details on study design:
- - Dose selection rationale: The dose selected was the maximum dose that could be applied on the side of the rabbits without runoff.
- Rationale for animal assignment: Not reported
TREATMENT: The treatment schedule was as follows:
- Control 1, 2 and 3: Animals were shaved, not treated.
- Group 1: Formulation 1 (P21) containing 1% of test substance was prepared. Prior to treatment, the formulation was mixed with equal volume of 6% hydrogen peroxide.
- Group 2: Formulation 2 (P22) contained 0.5% of test substance.
Examinations
- Observations and examinations performed and frequency:
- MORTALITY: Yes
- Time schedule: Time schedule was not specified in the study report.
CAGE SIDE OBSERVATIONS: No
DETAILED CLINICAL OBSERVATIONS: No
DERMAL IRRITATION: Yes
- Time schedule for examinations: Details on time schedule on observation of dermal irritation was not provided in the study report.
BODY WEIGHT: Yes
- Time schedule for examinations: Weekly
FOOD CONSUMPTION: No
FOOD EFFICIENCY: No
WATER CONSUMPTION: No
OPHTHALMOSCOPIC EXAMINATION: No
HAEMATOLOGY: Yes
- Time schedule for collection of blood: At 0, 3, 7, and 13 week of the study, the blood was collected by cardiac puncture
- Anaesthetic used for blood collection: No data
- Animals fasted: Yes
- How many animals: All
- Parameters checked: Complete blood count (HCT, Hb, RBC, WBC and Meb-Hb)
CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: At 0, 3, 7, and 13 week of the study. The clinical chemistry determinations were performed on blood obtained by cardiac puncture by SMA-12 analysis using the Technicon auto analyzer.
- Animals fasted: Yes
- How many animals: All
- Parameters checked: Methemoglobin, fasting blood sugar, blood urea nitrogen, alkaline phosphatase and serum glutamic oxaloacetic transaminase
URINALYSIS: Yes
- Time schedule for collection of urine: At 0, 3, 7, and 13 week of the study.
- Metabolism cages used for collection of urine: No data
- Animals fasted: Yes
- Parameters checked: Color, pH, albumin, glucose, occult blood and microscopic elements
NEUROBEHAVIOURAL EXAMINATION: No
ORGAN TO WEIGHT RATIO: Organ-body weight ratios were determined for liver, kidneys, adrenals, heart, thyroid, spleen, and brain. - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes, all survivors were sacrificed after 13 wk and examined for gross abnormalities.
HISTOPATHOLOGY: Yes
- Tissues collected: Twenty-five tissues {skin from treated and untreated areas, lymph nodes (mesenteric, axillary, and cervical), spleen, stomach, duodenum, colon, liver, gall bladder, adrenals, nerve with adjacent muscle, eyes, pancreas, kidneys, urinary bladder, ovaries, testes, bone, bone marrow, heart, lung, thyroid, brain, and skeletal muscle under the site of application and elsewhere (thigh) from each animal were stained with hematoxylin and eosin and examined microscopically. - Statistics:
- - Statistical analysis of the data on body weight gains, hematology, clinical chemistries, and absolute and relative organ weights was performed using the analysis of variance F test and Student's t test.
- When variances differed significantly, Student's t test was modified (t') and Cochran's approximation was utilized (Snedecor and Cochran, 1967).
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Dermal irritation:
- no effects observed
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- not examined
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- no effects observed
- Clinical biochemistry findings:
- no effects observed
- Urinalysis findings:
- no effects observed
- Behaviour (functional findings):
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- effects observed, treatment-related
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- not examined
- Details on results:
- MORTALITY
- Five control and five test animals died during the study due to complications resulting from cardiac puncture while collecting blood.
CLINICAL SIGNS:
- No evidence of test substance induced toxicity was seen. The treated skin showed slight thickening in some groups, particularly Group 1. This was not unexpected, due to the frequency of dye application.
BODY WEIGHT AND WEIGHT GAIN
- Body weight gain of all test groups was at least equal to that of the controls.
HAEMATOLOGY
- There were scattered statistically significant differences in the hematologic values between test and control groups at the various sampling intervals. However, these differences were not considered to be of toxicologically significant because of either the direction or continuity of the differences or the fact that they fell within the range of historical control values.
CLINICAL CHEMISTRY
- There were scattered statistically significant differences in the clinical chemistry values between test and control groups at the various sampling intervals. However, these differences were not considered to be of toxicologically significant because of either the direction or continuity of the differences or the fact that they fell within the range of historical control values. These symptoms were not accompanied with histomorphologic changes.
URINALYSIS
- The results of the urinalyses were unremarkable. No dye discoloration of the urine was seen at any time during the test.
GROSS PATHOLOGY
- No gross abnormalities were seen at necropsy.
HISTOPATHOLOGY: NON-NEOPLASTIC
- No microscopic lesions were seen that were judged to be due to the administration of the formulations.
ORGAN TO BODY WEIGHT RATIO:
- There were a few instances when there were statistically significant differences in relative organ weights between a test group and the combined controls where the differences were not significant when the group was compared with each control group separately.
OTHER
- The incidence and severity of disease processes was common to laboratory rabbits and it was not affected by the experimental treatments.
Effect levels
- Dose descriptor:
- NOAEL
- Remarks on result:
- not determinable
- Remarks:
- no NOAEL identified
Target system / organ toxicity
- Critical effects observed:
- no
Applicant's summary and conclusion
- Conclusions:
- Dermal application of P21 formulation containing 1% N,N-Bis-(2-hydroxyethyl)-p-phenylenediamine sulfate mixed with equal volume of hydrogen peroxide and dermal applicaton of P22 formulation containing 0.5% of test substance to hair clipped skin of rabbits for 13 weeks (twice/week) did not induce any evidence of systemic toxicity.
- Executive summary:
The study was performed to determine the toxicity of N,N-Bis-(2-hydroxyethyl)-p-phenylenediamine sulfate after repeated dermal application by following methods similar to the OECD Guideline 411 (Subchronic Dermal Toxicity: 90-Day Study).
Male and female New Zealand White rabbits were used in the study. 6 animals/sex were used in each group. The hair at the site of application on the back and sides of each animal was clipped short throughout the study. The thoracic-lumbar area (one on each side of the midline) was re alternated to minimize skin irritation. The application sites on three animals of each sex in each group were abraded on the first treatment day of each week.
1 mL/Kg bw of test substance formulation was applied. Animals were treated for 13 weeks (twice/week). The treatment schedule was as follows:Control 1, 2 and 3: Animals were shaved, not treated.
Group 1: Formulation 1 (P21) containing 1% of test substance was prepared. Prior to treatment, the formulation was mixed with equal volume of 6% hydrogen peroxide.
Group 2: Formulation 2 (P22) contained 0.5% of test substance
After 1 h of treatment, animals were shampooed, rinsed, dried, and returned to their cages.
Animals were observed for clinical signs, dermal irritation and body weight changes during the study period. Urine and blood samples were collected at 0, 3, 7, and 13 weeks of the study to determine the various parameters. Animals were sacrificed after 13 wk and examined for gross abnormalities. Tissue samples were collected to perform histology. Organ-body weight ratios were determined for liver, kidneys, adrenals, heart, thyroid, spleen, and brain.
Five control and five test animals died during the study due to complications resulting from cardiac puncture while collecting blood. Treated skin showed slight thickening in some groups, particularly Group 1. This was not unexpected, due to the frequency of dye application. No evidence of test substance induced toxicity was observed. Body weight gain of all test groups was at least equal to that of the controls.
There were scattered statistically significant differences in the hematologic and clinical chemistry values between test and control groups at the various sampling intervals. However, these differences were not considered to be of toxicological significance because of either the trend or persistence of the differences or the fact that they fell within the range of historical control values. The results of the urinalyses were unremarkable.
No gross abnormalities were seen at necropsy. No microscopic lesions were seen that were judged to be due to the administration of the formulations.
Based on above, dermal application of P21 formulation containing 1% N,N-Bis-(2-hydroxyethyl)-p-phenylenediamine sulfate mixed with equal volume of hydrogen peroxide and dermal application of P22 formulation containing 0.5% of test substance to hair clipped skin of rabbits for 13 weeks (twice/week) did not induce any evidence of systemic toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
